Tokyo Tape
Sign in
← Jmdc

Half-year report · Q2

4483.TEDINET S100UQ55
Period2024-04-01 → 2024-09-30
Filed2024-11-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥19.2bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥32.4bn2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥13.7bn2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥3.3bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income¥3.6bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax¥3.2bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax¥6.9bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥3.6bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥2.2bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥4.6bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥2.7bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥2.2bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income¥2.7bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥136.1bnat 2024-09-30Cons.Assets IFRS
Total assets¥122.5bnat 2024-03-31Cons.Assets IFRS
Total assets¥100.0bnat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥63.7bnat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥51.8bnat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥72.4bnat 2024-09-30Cons.Equity IFRS
Net assets / equity¥70.7bnat 2024-03-31Cons.Equity IFRS
Net assets / equity¥68.7bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥64.5bnat 2023-03-31dCons.Equity IFRS
Equity (owners)¥72.1bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥70.6bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥68.6bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥27.5bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥14.5bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥21.5bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥22.8bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥10.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥17m2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥2.0bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥4.5bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥24.9bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥3.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥6.7bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥16.6bn2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥341m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥33.512024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥71.762023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥42.22023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥33.182024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥69.952023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥40.532023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio52.9%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio57.6%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio68.6%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 35
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥21m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥21m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥379m
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2024-04-01 → 2024-09-30¥649m
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2024-04-01 → 2024-09-30¥649m
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2024-04-01 → 2024-09-30¥116m
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentrevenue2024-04-01 → 2024-09-30¥15.5bn
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentrevenue external2024-04-01 → 2024-09-30¥15.5bn
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥21m
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentsegment profit2024-04-01 → 2024-09-30¥3.8bn
jpcrp040300-q2r_E35308-000Tele Medicinereportable segmentrevenue2024-04-01 → 2024-09-30¥3.1bn
jpcrp040300-q2r_E35308-000Tele Medicinereportable segmentrevenue external2024-04-01 → 2024-09-30¥3.1bn
jpcrp040300-q2r_E35308-000Tele Medicinereportable segmentsegment profit2024-04-01 → 2024-09-30¥1.1bn
—segment totalrevenue2024-04-01 → 2024-09-30¥19.2bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥19.2bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥21m
—segment totalsegment profit2024-04-01 → 2024-09-30¥5.0bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥89m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥89m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥338m
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥50m
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2023-04-01 → 2023-09-30¥133m
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentrevenue2023-04-01 → 2023-09-30¥9.8bn
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentrevenue external2023-04-01 → 2023-09-30¥9.8bn
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥38m
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentsegment profit2023-04-01 → 2023-09-30¥2.5bn
jpcrp040300-q2r_E35308-000Tele Medicinereportable segmentrevenue2023-04-01 → 2023-09-30¥2.7bn
jpcrp040300-q2r_E35308-000Tele Medicinereportable segmentrevenue external2023-04-01 → 2023-09-30¥2.7bn
jpcrp040300-q2r_E35308-000Tele Medicinereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.0bn
—segment totalrevenue2023-04-01 → 2023-09-30¥13.8bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥13.7bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥89m
—segment totalsegment profit2023-04-01 → 2023-09-30¥3.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 769
ItemContextValueUnit
Basic earnings loss per share IFRSPrior1YTDDuration42.20
Basic earnings loss per share IFRSCurrentYTDDuration33.51
Diluted earnings loss per share IFRSPrior1YTDDuration40.53
Diluted earnings loss per share IFRSCurrentYTDDuration33.18
Profit loss IFRSPrior1YTDDuration2663000000JPY
Profit loss IFRSCurrentYTDDuration2211000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration5000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration294000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration5000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration294000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration-1000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration0JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration-1000000JPY
Total of items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration0JPY
Other comprehensive income IFRSPrior1YTDDuration3000000JPY
Other comprehensive income IFRSCurrentYTDDuration295000000JPY
Comprehensive income IFRSPrior1YTDDuration2667000000JPY
Comprehensive income IFRSCurrentYTDDuration2506000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration2666000000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration2484000000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1YTDDuration0JPY
Comprehensive income attributable to non controlling interests IFRSCurrentYTDDuration21000000JPY
Comprehensive income IFRSPrior1YTDDuration2667000000JPY
Comprehensive income IFRSCurrentYTDDuration2506000000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember23994000000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember27211000000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-2000000JPY
Equity IFRSPrior2YearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-4000000JPY
Equity IFRSPrior2YearInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Equity IFRSPrior2YearInstant_ShareAcquisitionRightsIFRSMember32000000JPY
Profit loss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-1000000JPY
Other comprehensive income IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember5000000JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-1000000JPY
Comprehensive income IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember5000000JPY
Comprehensive income IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Issuance of share acquisition rights ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Issuance of share acquisition rights ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass